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Abstract  
The objective of this article is to report our first experience of CT guided percutaneous thoracic biopsy and to demonstrate the accuracy and safety 
of this procedure. This was a retrospective study of 28 CT-Guided Percutaneous Needle Biopsies of the Chest performed on 24 patients between 
November 2014 and April 2015. Diagnosis was achieved in 18 patients (75%), negative results were found in 3 patients (12,5%). Biopsy was 
repeated in these cases with two positive results. Complications were seen in 7 patients (29%), Hemoptysis in 5 patients (20%), Pneumothorax in 
1 patient (4,1%) and vaso-vagal shock in 1 patient (4,1%). CT Guided Percutaneous Needle Biopsy of the Chest is a safe, minimally invasive 
procedure with high sensitivity, specificity and accuracy for diagnosis of lung lesions. 
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Introduction 
 
CT Guided Percutaneous Needle Biopsy of the Chest is a minimally 
invasive procedure frequently indicated for the diagnosis of lung 
lesions [1]. This technique was first described in 1976 [2] and CT 
guidance is the primary Imaging modality. Core needle biopsies 
provide high quality tissue samples for histologic analysis and 
immunohistochemical testing [3, 4]. Complications include 
pneumothorax, haemorrhage, air embolism and tumor seeding, with 
pneumothorax being the most frequent [5]. Throughout the world, 
this technique is useful and accurate in the diagnosis of peripheral 
masses. Our study demonstrates the accuracy of this technique, 
confirms its safety with low complication rates, especially with the 





24 patients were included to this retrospective study; they were 
admitted to the Thoracic surgery department between October 2014 
and April 2015. These patients underwent lung biopsies with a core 
needle biopsy device (16G or 18G) under CT guidance (SOMATOM 
Definition AS plus 128, Siemens Healthcare, Forchheim, Germany). 
All patients with peripheral masses suspicious for malignancy and 
without suspicion of vascular disease were included in this study. 
The patients were admitted one day before the procedure to the 
thoracic surgery department and a coagulation test was done 
(prothrombin time, activated prothrombin time and platelet count). 
One patient was on oral anticoagulants for atrial fibrillation 
(Coumadine*), the treatment was replaced with heparin 5 days 
before the procedure [6]. We informed patients about the benefits 
and risks of the procedure such as pneumothorax and haemorrhage 
and consent was obtained. A peripheral IV cannula was placed 
before installing patient in the CT scanner. All biopsies were done 
under CT guidance. The patient was positioned prone, supine or in 
lateral decubitus, according to the location of the lesion. The lesion 
was localised and the access route was planned using our Chest 
intervention protocol including a first 2 mm slice thickness 
acquisition used to localise the lesion, then the entry site was 
marked by a permanent marker, and distance between the skin 
surface and the lesion was measured. Then, the skin entry site and 
surrounding skin area was cleaned by povidone iodine solution and 
covered by sterile drapes. Local anaesthesia at the entry site and 
biopsy track was performed with 5 - 10 cc of Lidocaine 2%. A 17G, 
11 cm co axial needle (Angiotech, Argon Medical*) was placed in 
the predetermined route and Advanced carefully Under CT guidance 
to verify its position using 5 mm sequential acquisitions to minimize 
radiation exposure. Once the coaxial needle was in satisfactory 
position, it was Advanced rapidly through the pleura and placed at 
the edge or directly within the lesion. The inner part of the coaxial 
needle was removed and an 18 G 16 cm tru-cut semi automatic 
needle was placed to obtain 3 or 4 samples. The samples were 
placed in formalin solution and sent to Histopathology for analysis. 
The core needle biopsy device was removed and the entry site was 
covered with sterile gauze, then 2 mm axial slices covering the 
biopsy level were acquired to check for complications. Then the 
patients were transferred to observation room and placed on the 
opposite side to the entry site for biopsy and observed for 2 hours. 
Patients with pneumothorax were placed under nasal oxygen and a 
Chest X-ray was done 24 hours later to check the evolution of the 
pneumothorax. No chest tubes were inserted into any of our 





24 patients (23 males and 1 female) were included in our study. 
The patients' mean age was 62 years (43 - 90 years). 22 patients 
were active smokers. Mean lesion size was 43 mm and the median 
traversed parenchymal distance was 20 mm. 21 patients had 
peripheral lung lesions whereas 3 had central lesions. Lesions were 
solid in 10 patients, solid and necrotic in 11 patients and purely 
necrotic in 3 patients. Emphysema was seen in 10 patients and 
pneumothorax was sustained in 2 patients. A total of 27 biopsies 
were performed in 24 patients. Histopathology results were positive 
in 18 of 24 patients and negative in 3 patients who underwent a 
second biopsy. All had malignant lesions. 7 patients in our study 
developed complications (29,17%): Hemorrhage in 5 patients « 20, 
8% » (3 mild and 1 moderate); small volume pneumothorax in 1 
patient « 4,2% »; vasovagal shock in 1 patient « 4,2% ». Alveolar 
hemorrhage and pneumothorax resolved spontaneously with no 
need to proceed to other interventions. One patient who received 
anticoagulation for atrial fibrillation underwent biopsy. Their 
Warfarin was stopped 5 days before the procedure and replaced 
with heparin [6]. A small area of alveolar hemorrhage was seen on 
post-biopsy CT, without any associated clinical symptoms. 
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Discussion 
 
In our retrospective study on CT Guided Percutaneous Needle 
Biopsy, diagnostic accuracy rate was 75%. Non diagnostic biopsy 
rate was 12,5%. Complications were essentially alveolar 
hemorrhage (20, 8%) and pneumothorax (4,2%) in a smaller 
proportion. Spontaneous reabsorption of alveolar hemorrhage and 
pneumothorax was seen in all patients with no need to proceed to 
other interventions such as chest drain insertion. Percutaneous CT-
guided core needle biopsy is a safe procedure with a high accuracy 
for diagnosis of lung malignancies [7]. Our results confirm that CT 
Guided Percutaneous Lung Biopsy is a safe procedure allowing 
diagnosis of lung lesions in the majority of patients. Major 
complications were pneumothorax and hemorrhage with good 
outcomes and spontaneous reabsorption. The presence of 
emphysema was challenging, meaning a greater risk of 
pneumothorax, most common in our smoking patient population 
[8]. Deeper lesions require traversing a greater amount of lung 
parenchyma and increase the risk of pneumothorax and 
hemorrhage; we did not notice any of those incidents in our study. 
We thought that small anterior and lateral lesions were highly 
challenging to reach because of respiratory motion; so good 
communication with the patient and soft respiration were 
mandatory to successfully achieve the procedure with few or no 
complications. Limitations of our study were the small number of 





In conclusion, CT-guided percutaneous needle biopsy is a safe 
procedure with a high diagnostic accuracy rate in the diagnosis of 
malignant lung lesions. 
 
What is known about this topic 
 Percutaneous thoracic CT guided biopsy is an accurate 
procedure for diagnosis of lung malignancies; 
 Major complications are pneumothorax and alveolar 
hemorrhage; 




What this study adds 
 Percutaneous thoracic CT guided biopsy with 18 G co 
axial needle is a very safe procedure with lesser 
complication rate; 
 CT protocol used in this study limits the radiation 
exposure of patients; 
 The procedure can also be achieved in emphysematous 






















Figure 1: Axial CT image showing post procédural pneumothorax in 
65 years old man who underwent core needle biopsy of right 
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Figure 1: Axial CT image showing post procédural pneumothorax in 65 years old 
man who underwent core needle biopsy of right postéro basal mass 
 
